CompletedNot applicableNCT00978263

Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 Diabetes

Studying MODY

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chongqing Medical University
Principal Investigator
Qifu Li, PhD
the First Affiliated Hospital, Chongqing Medical University, China
Intervention
metformin-based Oral Antidiabetic Drugs(drug)
Enrollment
47 target
Eligibility
30-70 years · All sexes
Timeline
20092012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00978263 on ClinicalTrials.gov

Other trials for MODY

Additional recruiting or active studies for the same condition.

See all trials for MODY

← Back to all trials